Walter R. Maupay
Chairman at DSM Biomedical, Inc.
Profile
Walter R.
Maupay is currently the Chairman at DSM Biomedical, Inc. He previously held positions as Chairman & President at Calgon Vestal Laboratories, Inc., Director at SyntheMed, Inc., Director at PolyMedica Corp., and Director at Cubist Pharmaceuticals LLC.
He also served as Group Executive at Bristol Myers Squibb Co. and Divisional President at Merck & Co., Inc. Mr. Maupay holds an MBA from Lehigh University and an undergraduate degree from Temple University (Pennsylvania).
Walter R. Maupay active positions
| Companies | Position | Start |
|---|---|---|
DSM Biomedical, Inc.
 DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Chairman | 1995-05-31 |
Former positions of Walter R. Maupay
| Companies | Position | End |
|---|---|---|
SyntheMed, Inc.
 SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Director/Board Member | 2011-09-15 |
| CUBIST PHARMACEUTICALS INC | Director/Board Member | 2009-12-31 |
PolyMedica Corp.
 PolyMedica Corp. Specialty StoresRetail Trade PolyMedica Corp. develops and sells healthcare products and related services primarily to seniors. The firm offers blood glucose testing supplies and related services to diabetics. The company was founded in 1988 and is headquartered in Port St. Lucie, FL. | Director/Board Member | 2007-10-30 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 1994-12-31 |
Calgon Vestal Laboratories, Inc.
 Calgon Vestal Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of STERIS Plc (Ireland), Calgon Vestal Laboratories, Inc. is a company that specializes in skin care and infection control products. The company is based in New York, NY. Calgon Vestal Laboratories was acquired by Bristol Myers Squibb Co. from Merck & Co., Inc. on January 15, 1995 for $261.50 million. | Chairman | 1994-11-30 |
Training of Walter R. Maupay
| Temple University (Pennsylvania) | Undergraduate Degree |
| Lehigh University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 5 |
|---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
PolyMedica Corp.
PolyMedica Corp. Specialty StoresRetail Trade PolyMedica Corp. develops and sells healthcare products and related services primarily to seniors. The firm offers blood glucose testing supplies and related services to diabetics. The company was founded in 1988 and is headquartered in Port St. Lucie, FL. | Retail Trade |
DSM Biomedical, Inc.
DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Calgon Vestal Laboratories, Inc.
Calgon Vestal Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of STERIS Plc (Ireland), Calgon Vestal Laboratories, Inc. is a company that specializes in skin care and infection control products. The company is based in New York, NY. Calgon Vestal Laboratories was acquired by Bristol Myers Squibb Co. from Merck & Co., Inc. on January 15, 1995 for $261.50 million. | Health Technology |
- Stock Market
- Insiders
- Walter R. Maupay